OpportunityTitle: Improving Access to Overdose Treatment
AdditionalInformationOnEligibility: Eligibility is limited to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations, and practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act (including secondary and higher education settings).
Description: The purpose of this program is to expand access to naloxone and other Food and Drug Administration (FDA) approved overdose reversal medications for emergency treatment of known or suspected opioid overdose. The recipients will collaborate with other prescribers at the community level to implement trainings on policies, procedures, and models of care for prescribing, co-prescribing, and expanding access to naloxone and other FDA-approved overdose reversal medications to the specified population of focus (i.e., rural or urban).
GrantorContactEmailDescription: FOACSAT@samhsa.hhs.gov
GrantorContactText: Office of Financial Resources, Division of Grants Management &lt;br/&gt;Substance Abuse and Mental Health Services Administration &lt;br/&gt;(240) 276-1400